↓ Skip to main content

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda

Overview of attention for article published in BMC Infectious Diseases, February 2010
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

policy
1 policy source
facebook
1 Facebook page
googleplus
1 Google+ user

Citations

dimensions_citation
88 Dimensions

Readers on

mendeley
180 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda
Published in
BMC Infectious Diseases, February 2010
DOI 10.1186/1471-2334-10-41
Pubmed ID
Authors

Heidi Albert, Freddie Bwanga, Sheena Mukkada, Barnabas Nyesiga, Julius Patrick Ademun, George Lukyamuzi, Melles Haile, Sven Hoffner, Moses Joloba, Richard O'Brien

Abstract

About 500 new smear-positive Multidrug-resistant tuberculosis (MDR-TB) cases are estimated to occur per year in Uganda. In 2008 in Kampala, MDR-TB prevalence was reported as 1.0% and 12.3% in new and previously treated TB cases respectively. Line probe assays (LPAs) have been recently approved for use in low income settings and can be used to screen smear-positive sputum specimens for resistance to rifampicin and isoniazid in 1-2 days.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 180 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 5 3%
South Africa 2 1%
Tanzania, United Republic of 1 <1%
Austria 1 <1%
Kenya 1 <1%
Brazil 1 <1%
Sudan 1 <1%
United Kingdom 1 <1%
Zimbabwe 1 <1%
Other 2 1%
Unknown 164 91%

Demographic breakdown

Readers by professional status Count As %
Student > Master 41 23%
Researcher 34 19%
Student > Ph. D. Student 20 11%
Student > Postgraduate 17 9%
Student > Bachelor 17 9%
Other 26 14%
Unknown 25 14%
Readers by discipline Count As %
Medicine and Dentistry 67 37%
Agricultural and Biological Sciences 34 19%
Immunology and Microbiology 17 9%
Nursing and Health Professions 9 5%
Biochemistry, Genetics and Molecular Biology 8 4%
Other 13 7%
Unknown 32 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 July 2021.
All research outputs
#6,248,214
of 22,678,224 outputs
Outputs from BMC Infectious Diseases
#1,914
of 7,642 outputs
Outputs of similar age
#29,892
of 93,500 outputs
Outputs of similar age from BMC Infectious Diseases
#17
of 37 outputs
Altmetric has tracked 22,678,224 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 7,642 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 93,500 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.